Background: Blimp-1 has long been recognized as master regulator for B cell development and has additionally been recognized as important rheostat, balancing effector function and T cell exhaustion. Although several studies described Blimp-1 in the context of T cell exhaustion in viral infections, the role of Blimp-1 was first and primarily defined as a “master regulator” of terminal B cell development. Blimp-1 attenuates the expression of many transcription factors, thereby inhibiting B cell proliferation and B cell receptor mediated activation while promoting immunoglobulin secretion and plasma cell differentiation. Here, we present novel data describing the expression pattern of Blimp-1 in different B cell memory subsets in a cohort of viremic and treated HIV-1 patients.
Methods: The expression of Blimp-1 in different B cell memory subsets was analyzed by flow cytometry in a cohort of 26 individuals, classified as healthy donors (n = 7), treatment naïve HIV-1 infected patients (n = 9) and HIV-1 infected patients under antiretroviral therapy (cART) (n = 10). B cell memory subsets were defined as activated memory B cells (CD20+/CD21lo/CD27int), tissue like memory B cells (CD20+/CD21lo/CD27–), resting memory B cells CD20+/CD21hi/CD27int) and naïve memory B cells (CD20+/CD21lo/CD27lo).
Results: The expression of Blimp-1 on activated memory B cells was significantly down-regulated in patients with HIV-1 infection compared to healthy donors. Viremic, treatment naïve patients showed an even lower expression of Blimp-1 than patients on cART. The relative frequency of Ki67 on activated memory B cells directly correlated with HIV viral load (p = 0.005, r2 = 0.30). Additionally, the relative frequency of Blimp-1 on activated memory B cells inversely correlated with HIV-1 viral loads and the relative frequency of Ki67+ activated memory B cells (p = 0.026, r2 = 0.62; p = 0.033, r2 = 0.51) (Figure 1).
Conclusions: To our knowledge, this alteration of Blimp-1 expression on activated memory B cells in patients with HIV-1 infection has not been described before. We propose to further investigate the hypothesis whether down-regulation of Blimp-1 expression on activated memory B cells in patients with HIV-1 infection leads to uncontrolled differentiation into antibody secreting cells and consequently to an impaired production of neutralizing antibodies that has been described in HIV infection.